Syncope as initial symptom of ostial lesion of the left main coronary artery with cardiogenic shock
Abstract
Introduction. Syncope represents a relatively atypical symptom of acute coronary syndrome. Syncope itself does not provide enough information to indicate an acute coronary event, especially a lesion of the left main coronary artery, without malignant rhythm and conduction disorders. Case report. A male patient, aged 63, was admitted to the intensive cardiac care unit because of a short loss of consciousness, in sinus tachycardia, with signs of acute heart failure and being hypotensive. Electrocardiogram showed a possible acute anterior myocardial infarction, followed by cardiogenic shock and emergency coronary angiography (subocclusive ostial lesion of the left main coronary artery) and primary percutaneous coronary intervention with intra-aortic balloon pump therapy was performed. A direct drug eluting stent was implanted with the optimal primary result. Conclusion. The prompt diagnosis, especially in such relatively atypical clinical presentation, reperfusion therapy with primary percutaneous coronary intervention in acute myocardial infarction complicated by cardiogenic shock, contribute to the improvement in the survival rate and patient's quality of life. This case report is clinically educative due to relatively atypical presentation and performed interventions.
References
Lemonick DM. Evaluation of Syncope in the emergency de-partment. Am J Clin Med 2010; 7(1): 11−9.
McDermott D, Quinn JV, Murphy CE. Acute myocardial infarc-tion in patients with syncope. CJEM 2009; 11(2): 156−60.
Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Associa-tion, Society for Cardiovascular Angiography and Interven-tions, and Society of Thoracic Surgeons. Circulation 2012; 126(25): 3097−137.
Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive SummaryA Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 2011; 58(24): 2550−83.
Ohman EM, Nanas J, Stomel RJ, Leesar MA, Nielsen DW, O'Dea D, et al. Thrombolysis and counterpulsation to improve sur-vival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS Trial. J Thromb Thrombolysis 2005; 19(1): 33−9.
Wasek W, Kułakowski P, Czepiel A, Kłosiewicz-Wasek B, Budaj A, Soszyńska M, et al. Susceptibility to neuromediated syncope af-ter acute myocardial infarction. Eur J Clin Invest 2000; 30(5): 383−8.
Sarasin FP, Junod AF, Carballo D, Slama S, Unger PF, Louis-Simonet M. Role of echocardiography in the evaluation of syn-cope: a prospective study. Heart 2002; 88(4): 363−7.
Chieffo A, Park SJ, Valgimigli M, Kim YH, Daemen J, Sheiban I, et al. Favorable long-term outcome after drug-eluting stent im-plantation in nonbifurcation lesions that involve unprotected left main coronary artery: a multicenter registry. Circulation 2007; 116(2): 158−62.
Morice MC, Serruys PW, Kappetein AP, Feldman TE, Ståhle E, Co-lombo A, et al. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary In-tervention with TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation 2010; 121(24): 2645−53.
Kushner FG, Hand M, Smith SC Jr, King SB 3rd, Anderson JL, Antman EM, et al. 2009 focused updates: ACC/AHA Guide-lines for the Management of Patients with ST-Elevation Myo-cardial Infarction (updating the 2004 guideline and 2007 fo-cused update) and ACC/AHA/SCAI Guidelines on Percuta-neous Coronary Intervention (updating the 2005 guideline and 2007 focused update). Circulation 2009; 120(22): 2271–306.
Lee MS, Bokhoor P, Park SJ, Kim YH, Stone GW, Sheiban I, et al. Unprotected left main coronary disease and ST-segment elevation myocardial infarction: a contemporary review and argument for percutaneous coronary intervention. JACC Cardiovasc Interv 2010; 3(8): 791−5.
Pandya SB, Kim YH, Meyers SN, Davidson CJ, Flaherty JD, Park DW, et al. Drug-eluting versus bare-metal stents in unpro-tected left main coronary artery stenosis a meta-analysis. JACC Cardiovasc Interv 2010; 3(6): 602−11.
Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33(20): 2569−619.
De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010; 362(9): 779−89.
French JK, Feldman HA, Assmann SF, Sanborn T, Palmeri ST, Mil-ler D, et al. Influence of thrombolytic therapy, with or without intra-aortic balloon counterpulsation, on 12-month survival in the SHOCK trial. Am Heart J 2003; 146(5): 804−10.
Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, et al. Investigators. Intraaortic balloon support for myo-cardial infarction with cardiogenic shock. N Engl J Med 2012; 367(14): 1287−96.
Bahekar A, Singh M, Singh S, Bhuriya R, Ahmad K, Khosla S, et al. Cardiovascular outcomes using intra-aortic balloon pump in high-risk acute myocardial infarction with or without cardi-ogenic shock: a meta-analysis. J Cardiovasc Pharmacol Ther 2012; 17(1): 44−56.